Herbs (Global Traditional) · Traditional Chinese Medicine
Rhodiola (Rhodiola rosea) (Rhodiola rosea)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Rhodiola rosea is an adaptogenic herb containing rosavins and salidroside that modulates the hypothalamic-pituitary-adrenal axis. These compounds inhibit stress-induced cortisol release and enhance cellular energy metabolism through mitochondrial function optimization.
Rhodiola rosea is a perennial plant from the Crassulaceae family native to high-altitude regions of Eastern Europe and Asia. The supplement is derived from dried roots and rhizomes using aqueous, hydroethanolic (up to 70% ethanol), or supercritical CO₂ extraction methods. This adaptogenic herb contains approximately 140 compounds including phenolic compounds, glycosides, and monoterpene derivatives.
The provided research dossier focuses exclusively on chemical composition analysis and extraction methodology, with no clinical trials, RCTs, or meta-analyses included. No PubMed PMIDs for clinical studies were available in the research materials. Additional clinical literature would be required to establish evidence-based health claims.
The research provides extraction ratios (3-5:1 for hydroethanolic extraction) and manufacturing specifications but does not include clinically studied dosage ranges for human consumption. Standardization typically focuses on salidroside and rosavin content. Consult a healthcare provider before starting any new supplement.
Rhodiola rosea root and rhizome contain a complex array of bioactive compounds rather than significant macronutrient content. Primary bioactive constituents include: Rosavins (rosavin, rosin, rosarin) at approximately 3-6% dry weight in standardized extracts (minimum 3% rosavin per pharmacopeial standards); Salidroside (p-tyrosol glucoside) at approximately 0.8-1.2% dry weight, considered a key marker compound alongside rosavins; p-Tyrosol (aglycone of salidroside) at trace to 0.1% levels. Flavonoids present include quercetin, luteolin, and catechin at combined concentrations of approximately 1-2% dry weight. Phenylpropanoids including triandrin and tyrosol contribute to the phenolic profile. Organic acids identified include oxalic acid, citric acid, malic acid, and succinic acid at minor concentrations. L-ascorbic acid (Vitamin C) is present at low levels estimated at 20-50 mg per 100g dry weight. Glucaric acid and gallic acid derivatives are present at trace levels. Tannins contribute approximately 8-18% of dry weight depending on plant part. Essential oils constitute approximately 0.05% including geraniol, myrtenol, and carvacrol. Mineral content includes modest amounts of manganese, zinc, and selenium, though concentrations vary significantly by geographic origin. Protein content is negligible (<2% dry weight). Carbohydrates present primarily as polysaccharides and glycosides. Bioavailability note: Salidroside demonstrates higher oral bioavailability than rosavins; co-administration with food may reduce peak plasma concentrations but extend absorption window. Standardized extracts (3% rosavin, 1% salidroside) are used in most clinical contexts to ensure consistent bioactive delivery.
Rhodiola's primary bioactive compounds rosavins and salidroside regulate the hypothalamic-pituitary-adrenal axis by inhibiting stress-activated protein kinase pathways. Salidroside enhances ATP synthesis through improved mitochondrial electron transport chain function. The herb also modulates monoamine neurotransmitters including serotonin, dopamine, and norepinephrine by inhibiting monoamine oxidase enzymes.
Most rhodiola research consists of small-scale studies with 40-100 participants examining stress and fatigue outcomes. A systematic review of 11 randomized controlled trials found modest improvements in stress-related fatigue and cognitive performance with 200-400mg daily doses. Several studies reported 10-20% improvements in mental fatigue scores, though many trials had methodological limitations including short duration and lack of standardized extracts. Larger, longer-term studies are needed to establish definitive clinical efficacy.
Rhodiola is generally well-tolerated with mild side effects including dizziness, dry mouth, and sleep disturbances in some users. The herb may enhance the effects of antidepressant medications, particularly MAOIs and SSRIs, requiring medical supervision. Rhodiola can potentially lower blood sugar levels, warranting caution in diabetic patients taking glucose-lowering medications. Pregnancy and breastfeeding safety data is insufficient, making use inadvisable during these periods.
